Pharminent

NICE backs expanded use of Brilique in final guidance

AZ’s maintenance therapy recommended for
long-term use, post-heart attack http://www.pmlive.com/pharma_news/nice_backed_expanded_use_of_brilique_in_final_guidance_1175654

Filed under: Cardiovascular